Africa Ready Malaria Screening - Trial NCT06153862
Access comprehensive clinical trial information for NCT06153862 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Ghana and is currently Recruitment Completed. The study focuses on Malaria. Target enrollment is 1640 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Ghana
Timeline & Enrollment
N/A
Sep 23, 2022
Sep 01, 2025
Primary Outcome
MSP1-19 malaria antigen
Summary
This study aims to develop immuno-analytical assays for testing the titres of malaria
 antibodies in Ghanaian patients' and/or donors' sera using a recombinantly produced MSP119
 fusion protein and/or MSP119-derived synthetic peptides as antigens.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06153862
Non-Device Trial